KEGG   PATHWAY: ko05340
Entry
ko05340                     Pathway                                
Name
Primary immunodeficiency
Description
Primary immunodeficiencies (PIs) are a heterogeneous group of disorders, which affect cellular and humoral immunity or non-specific host defense mechanisms mediated by complement proteins, and cells such as phagocytes and natural killer (NK) cells. These disorders of the immune system cause increased susceptibility to infection, autoimmune disease, and malignancy. Most of PIs are due to genetic defects that affect cell maturation or function at different levels during hematopoiesis. Disruption of the cellular immunity is observed in patients with defects in T cells or both T and B cells. These cellular immunodeficiencies comprise 20% of all PIs. Disorders of humoral immunity affect B-cell differentiation and antibody production. They account for 70% of all PIs.
Class
Human Diseases; Immune disease
Pathway map
ko05340  Primary immunodeficiency
ko05340

Disease
H01725  Primary immunodeficiency disease
Orthology
K01488  add, ADA; adenosine deaminase [EC:3.5.4.4]
K03160  TNFRSF5, CD40; tumor necrosis factor receptor superfamily member 5
K03161  TNFSF5, CD40L, CD154; tumor necrosis factor ligand superfamily member 5
K03648  UNG, UDG; uracil-DNA glycosylase [EC:3.2.2.27]
K05070  IL2RG, CD132; interleukin 2 receptor gamma
K05072  IL7R, CD127; interleukin 7 receptor
K05150  TNFRSF13B, TACI, CD267; tumor necrosis factor receptor superfamily member 13B
K05151  TNFRSF13C, BAFFR, CD268; tumor necrosis factor receptor superfamily member 13C
K05653  ABCB2, TAP1; ATP-binding cassette, subfamily B (MDR/TAP), member 2 [EC:7.4.2.14]
K05654  ABCB3, TAP2; ATP-binding cassette, subfamily B (MDR/TAP), member 3 [EC:7.4.2.14]
K05856  LCK; lymphocyte cell-specific protein tyrosine kinase [EC:2.7.10.2]
K06450  CD3D; T-cell surface glycoprotein CD3 delta chain
K06451  CD3E; T-cell surface glycoprotein CD3 epsilon chain
K06454  CD4; T-cell surface glycoprotein CD4
K06458  CD8A; T-cell surface glycoprotein CD8 alpha chain
K06459  CD8B; T-cell surface glycoprotein CD8 beta chain
K06465  CD19; B-lymphocyte antigen CD19
K06478  PTPRC, CD45; receptor-type tyrosine-protein phosphatase C [EC:3.1.3.48]
K06506  CD79A, IGA; CD79A antigen
K06554  IGLL1, IGLL, CD179b; immunoglobulin lambda-like polypeptide 1
K06713  ICOS, AILIM, CD278; inducible T-cell co-stimulator
K06856  IGH; immunoglobulin heavy chain
K07210  IKBKG, IKKG, NEMO; inhibitor of nuclear factor kappa-B kinase subunit gamma
K07360  ZAP70; tyrosine-protein kinase ZAP-70 [EC:2.7.10.2]
K07370  BTK; Bruton agammaglobulinemia tyrosine kinase [EC:2.7.10.2]
K07371  BLNK; B-cell linker protein
K08060  CIITA; MHC class II transactivator [EC:2.7.11.1]
K08061  RFX5; regulatory factor X 5
K08062  RFXANK; regulatory factor X-associated ankyrin-containing protein
K08063  RFXAP; regulatory factor X-associated protein
K10603  AIRE; autoimmune regulator
K10628  RAG1; V(D)J recombination-activating protein 1 [EC:2.3.2.27]
K10887  DCLRE1C, ARTEMIS, SCIDA; DNA cross-link repair 1C protein [EC:3.1.-.-]
K10988  RAG2; recombination-activating protein 2
K10989  AICDA, AID; activation-induced cytidine deaminase [EC:3.5.4.38]
K11218  JAK3; Janus kinase 3 [EC:2.7.10.2]
K16056  ORAI1; calcium release-activated calcium channel protein 1
Reference
  Authors
Cunningham-Rundles C, Ponda PP.
  Title
Molecular defects in T- and B-cell primary immunodeficiency diseases.
  Journal
Nat Rev Immunol 5:880-92 (2005)
DOI:10.1038/nri1713
Reference
  Authors
Ballow M.
  Title
Primary immunodeficiency disorders: antibody deficiency.
  Journal
J Allergy Clin Immunol 109:581-91 (2002)
DOI:10.1067/mai.2002.122466
Reference
  Authors
Marodi L, Notarangelo LD.
  Title
Immunological and genetic bases of new primary immunodeficiencies.
  Journal
Nat Rev Immunol 7:851-61 (2007)
DOI:10.1038/nri2195
Reference
  Authors
Geha RS, Notarangelo LD, Casanova JL, Chapel H, Conley ME, Fischer A, Hammarstrom L, Nonoyama S, Ochs HD, Puck JM, Roifman C, Seger R, Wedgwood J.
  Title
Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee.
  Journal
J Allergy Clin Immunol 120:776-94 (2007)
DOI:10.1016/j.jaci.2007.08.053
Reference
  Authors
Fischer A.
  Title
Human primary immunodeficiency diseases.
  Journal
Immunity 27:835-45 (2007)
DOI:10.1016/j.immuni.2007.11.012
Reference
  Authors
Fischer A.
  Title
Human primary immunodeficiency diseases: a perspective.
  Journal
Nat Immunol 5:23-30 (2004)
DOI:10.1038/ni1023
Reference
  Authors
Buckley RH.
  Title
Primary immunodeficiency diseases due to defects in lymphocytes.
  Journal
N Engl J Med 343:1313-24 (2000)
DOI:10.1056/NEJM200011023431806
Reference
  Authors
Fischer A, Le Deist F, Hacein-Bey-Abina S, Andre-Schmutz I, Basile Gde S, de Villartay JP, Cavazzana-Calvo M.
  Title
Severe combined immunodeficiency. A model disease for molecular immunology and therapy.
  Journal
Immunol Rev 203:98-109 (2005)
DOI:10.1111/j.0105-2896.2005.00223.x
Reference
  Authors
de Villartay JP, Fischer A, Durandy A.
  Title
The mechanisms of immune diversification and their disorders.
  Journal
Nat Rev Immunol 3:962-72 (2003)
DOI:10.1038/nri1247
Related
pathway
ko04640  Hematopoietic cell lineage
ko04660  T cell receptor signaling pathway
ko04662  B cell receptor signaling pathway

DBGET integrated database retrieval system